Three cases were characterized by NCOA4-RET, CCDC6-RET, and SND1-BRAF fusions, which are more commonly seen in papillary thyroid carcinoma (Gao et al. 2018). This evidence concerns the gene BRAF and differentiated thyroid carcinoma.